DE69900220D1 - Diaza-spiro[3,5]nonan-Derivate - Google Patents

Diaza-spiro[3,5]nonan-Derivate

Info

Publication number
DE69900220D1
DE69900220D1 DE69900220T DE69900220T DE69900220D1 DE 69900220 D1 DE69900220 D1 DE 69900220D1 DE 69900220 T DE69900220 T DE 69900220T DE 69900220 T DE69900220 T DE 69900220T DE 69900220 D1 DE69900220 D1 DE 69900220D1
Authority
DE
Germany
Prior art keywords
diaza
spiro
nonane derivatives
nonane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69900220T
Other languages
English (en)
Other versions
DE69900220T2 (de
Inventor
Geo Adam
Andrea Cesura
Francois Jenck
Sabine Kolczewski
Stephan Roever
Juergen Wichmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69900220D1 publication Critical patent/DE69900220D1/de
Publication of DE69900220T2 publication Critical patent/DE69900220T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69900220T 1998-06-12 1999-06-07 Diaza-spiro[3,5]nonan-Derivate Expired - Lifetime DE69900220T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110804 1998-06-12

Publications (2)

Publication Number Publication Date
DE69900220D1 true DE69900220D1 (de) 2001-09-20
DE69900220T2 DE69900220T2 (de) 2002-05-08

Family

ID=8232114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69900220T Expired - Lifetime DE69900220T2 (de) 1998-06-12 1999-06-07 Diaza-spiro[3,5]nonan-Derivate

Country Status (28)

Country Link
US (1) US6113527A (de)
EP (1) EP0970957B1 (de)
JP (1) JP3286268B2 (de)
KR (1) KR100344732B1 (de)
CN (1) CN1107066C (de)
AR (1) AR019859A1 (de)
AT (1) ATE204279T1 (de)
AU (1) AU743983B2 (de)
BR (1) BR9902651A (de)
CA (1) CA2274202A1 (de)
DE (1) DE69900220T2 (de)
DK (1) DK0970957T3 (de)
ES (1) ES2162503T3 (de)
HR (1) HRP990188A2 (de)
HU (1) HU220894B1 (de)
ID (1) ID23304A (de)
IL (1) IL130377A0 (de)
MA (1) MA26644A1 (de)
NO (1) NO312590B1 (de)
NZ (1) NZ336189A (de)
PE (1) PE20000548A1 (de)
PL (1) PL333695A1 (de)
PT (1) PT970957E (de)
SG (1) SG79259A1 (de)
SI (1) SI0970957T1 (de)
TR (1) TR199901381A2 (de)
YU (1) YU26499A (de)
ZA (1) ZA993852B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005502619A (ja) * 2001-07-02 2005-01-27 オメロス コーポレイション オピオイドレセプター様レセプター１アゴニストと交替でオピオイドレセプターアゴニストを投与することを含む、痛覚脱失を生成するための方法
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
AU2003220886A1 (en) 2002-03-29 2003-10-13 Mitsubishi Pharma Corporation Remedy for sleep disturbance
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
EP1519939B9 (de) * 2002-07-05 2011-04-06 Targacept, Inc. N-aryl diazaspirozyklische verbindungen, deren verwendung und das verfahren zu ihren herstellung
NZ538307A (en) * 2002-09-09 2008-04-30 Janssen Pharmaceutica Nv Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
GB0323204D0 (en) * 2003-10-03 2003-11-05 Novartis Ag Organic compounds
WO2005060947A2 (en) * 2003-12-19 2005-07-07 Sri International Agonist and antagonist ligands of the nociceptin receptor
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
AU2005277410B2 (en) * 2004-08-20 2010-06-24 Targacept, Inc. The use of N-aryl diazaspiracyclic compounds in the treatment of addiction
US20080247964A1 (en) * 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
EA200970517A1 (ru) * 2006-11-28 2009-12-30 Янссен Фармацевтика Н.В. Соли 3-(3-амино-2-(r)-гидроксипропил)-1-(4-фторфенил)-8-(8-метилнафталин-1-илметил)-1,3,8-триазаспиро[4,5]декан-4-она
WO2008124209A1 (en) * 2007-04-09 2008-10-16 Janssen Pharmaceutica, N.V. 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
KR101704226B1 (ko) 2015-06-30 2017-02-07 현대자동차주식회사 자동차의 쿼터글라스 어셈블리
WO2023122662A1 (en) * 2021-12-22 2023-06-29 The Regents Of The University Of California Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!

Also Published As

Publication number Publication date
SI0970957T1 (de) 2001-12-31
KR100344732B1 (ko) 2002-07-19
PE20000548A1 (es) 2000-07-15
HU9901911D0 (en) 1999-08-30
HRP990188A2 (en) 2000-02-29
US6113527A (en) 2000-09-05
NZ336189A (en) 2000-10-27
PL333695A1 (en) 1999-12-20
CN1107066C (zh) 2003-04-30
DK0970957T3 (da) 2001-12-03
HUP9901911A1 (hu) 2000-05-28
EP0970957B1 (de) 2001-08-16
CN1242366A (zh) 2000-01-26
ES2162503T3 (es) 2001-12-16
DE69900220T2 (de) 2002-05-08
AR019859A1 (es) 2002-03-20
MA26644A1 (fr) 2004-12-20
NO992873L (no) 1999-12-13
AU743983B2 (en) 2002-02-14
TR199901381A3 (tr) 2000-01-21
PT970957E (pt) 2002-02-28
EP0970957A1 (de) 2000-01-12
ZA993852B (en) 1999-12-13
NO312590B1 (no) 2002-06-03
AU3498799A (en) 1999-12-23
YU26499A (sh) 2002-09-19
CA2274202A1 (en) 1999-12-12
NO992873D0 (no) 1999-06-11
JP3286268B2 (ja) 2002-05-27
BR9902651A (pt) 2000-05-16
ID23304A (id) 2000-04-05
TR199901381A2 (xx) 2000-01-21
JP2000053679A (ja) 2000-02-22
KR20000006060A (ko) 2000-01-25
SG79259A1 (en) 2001-03-20
ATE204279T1 (de) 2001-09-15
IL130377A0 (en) 2000-06-01
HU220894B1 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
DE69800896T2 (de) 8-substituierte-1,3,8-Triazaspiro[4,5]decan-4-onderivate
IS5722A (is) Pýróló [2,3-dl]pírimídín efnasambönd
DE69804273T2 (de) 5h-Thiazolo[3,2-a]pyrimidinderivate
CZ20011556A3 (cs) Pyrazolopyridinové deriváty
DE69915675D1 (de) Triazolo[4,5-d]pyrimidin-derivate
NO20020391D0 (no) 8-Fenyl-6,9-dihydro-[1,2,4]-triazolo-[3,4-i]-purin-5-on- derivater
PT930302E (pt) Derivados de benzo-sulfona
DE69803653T2 (de) 1,3,8-Triazaspiro[4,5]decan-4-on-derivate
DE69900220T2 (de) Diaza-spiro[3,5]nonan-Derivate
PT928790E (pt) Derivados de tiazolo
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
AU5065999A (en) Naphthyridine derivatives
NO20013384D0 (no) Imidazo[4,5-c]pyridin-4-on-derivater
DE69725182D1 (de) 5H PYRROLO[2,1-c][1,4]BENZODIAZEPIN-3-CARBOXAMIDDERIVATE
PT1056716E (pt) Derivados de ciclo-hexanodiolo
DE69905798D1 (de) Di- oder Triazaspiro[4,5]decanderivate
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
ID23283A (id) SPIRO [PIPERIDINA-4,1'-PIROLO (3,4-c) PIROLO]
PT1123283E (pt) Derivados de tiazole
PT1010699E (pt) Derivados de 3-oxadiazolil-1,6-naftiridina-2(h)-ona substituido em 5
PT928793E (pt) Derivados de tiazol
ZA985559B (en) Tetrahydroimidazo Ä2,1-aÜsoquinoline derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition